Skip to main content
main-content

Zeitschrift

Breast Cancer Research

Breast Cancer Research 2/2008

Sonderheft 2/2008

Breast Cancer Research 2008

Inhaltsverzeichnis ( 104 Artikel )

01.05.2008 | Lecture presentation | Sonderheft 2/2008

Molecular diversity of human breast cancer: clinical and therapeutic implications

01.05.2008 | Lecture presentation | Sonderheft 2/2008

Chromosomal instability in the pathogenesis and treatment of breast cancer

01.05.2008 | Lecture presentation | Sonderheft 2/2008

Surviving breast cancer: can women expect to 'get back to normal'?

01.05.2008 | Oral presentation | Sonderheft 2/2008

Use of BRCA1 protein:protein interactions to classify cancer risk

01.05.2008 | Oral presentation | Sonderheft 2/2008

Activation of TGF-beta signalling in breast cancer metastatic cells

01.05.2008 | Oral presentation | Sonderheft 2/2008

Development of breast cancer immunotherapy using MUC1-retargeted T lymphocytes

01.05.2008 | Oral presentation | Sonderheft 2/2008

Dietary patterns across the life course, mammographic density and implications for breast cancer: results from a British prospective cohort

01.05.2008 | Oral presentation | Sonderheft 2/2008

Loss of oestrogen receptor alpha in long-term antioestrogen-resistant cells: reversal by a c-src inhibitor

01.05.2008 | Oral presentation | Sonderheft 2/2008

Suppression of the NF-κB cofactor Bcl3 inhibits mammary epithelial cell apoptosis and, in breast tumours, correlates with poor prognosis

01.05.2008 | Poster presentation | Sonderheft 2/2008

Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival

01.05.2008 | Poster presentation | Sonderheft 2/2008

Two functionally distinct epithelial progenitors exist within the luminal cell compartment of the mouse mammary gland

01.05.2008 | Poster presentation | Sonderheft 2/2008

Interactions between BRCA2 protein and the meiosis-specific recombinase DMC1

01.05.2008 | Poster presentation | Sonderheft 2/2008

Lineage commitment in mammary epithelium is regulated by type 2 cytokines and Stat6

01.05.2008 | Poster presentation | Sonderheft 2/2008

Topoisomerase II expression as a determinant of chromosomal radiosensitivity and possible susceptibility in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Chromosome translocations in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

ZNF366 is a novel corepressor for estrogen receptor alpha that mediates its effects through interaction with CtBP

01.05.2008 | Poster presentation | Sonderheft 2/2008

A novel role for C-terminal binding proteins in the regulation of mitotic fidelity in breast cancer cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

RASSF2 can suppress the growth of breast cancer cell lines and is epigenetically inactivated in breast tumours

01.05.2008 | Poster presentation | Sonderheft 2/2008

Role of poly(ADPribosyl)ation of CTCF in cancer and normal breast cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

NRG1is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

01.05.2008 | Poster presentation | Sonderheft 2/2008

p53β isoform modulates differentially p53 transcriptional activity in response to stress

01.05.2008 | Poster presentation | Sonderheft 2/2008

Inhibitor of apoptosis proteins as a therapeutic target in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Cellular localization of the proto-oncogenic p53 inhibitor AGR2 protein in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Investigating h-Prune activation of Wnt signalling in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Coactivation of estrogen receptor alpha by the DEAD-box RNA helicases p68 and p72 and its role in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

TSC22 in mammary gland development and breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Accurate prediction of BRCA1 and BRCA2 heterozygous genotypes using expression profiling of lymphocytes after irradiation-induced DNA damage

01.05.2008 | Poster presentation | Sonderheft 2/2008

Investigation into the molecular mechanism of the antiapoptotic functions of CTCF in breast cancer cells using a proteomics approach

01.05.2008 | Poster presentation | Sonderheft 2/2008

Inhibition of apoptosis by Notch signalling in breast epithelial cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

TopBP1 contains transcriptional regulatory domains and regulates gene pathways involved in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Regulation of cyclin D1by the BRCA1–BARD1 complex

01.05.2008 | Poster presentation | Sonderheft 2/2008

Modelling estrogen receptor alpha-positive breast cancer by transformation of normal human mammary epithelial cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis

01.05.2008 | Poster presentation | Sonderheft 2/2008

Reelin expression in breast tumours is associated with increased survival and is controlled by promoter methylation

01.05.2008 | Poster presentation | Sonderheft 2/2008

Investigation of the roles of novel apoptosis-controlling genes in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

D133p53 isoform is a direct p53 target gene that modulates p53 tumour suppressor activity

01.05.2008 | Poster presentation | Sonderheft 2/2008

De novo expression of αvβ6 integrin by myoepithelial cells in ductal carcinoma in situ may be an important marker of disease progression

01.05.2008 | Poster presentation | Sonderheft 2/2008

Understanding and exploiting changes in O-linked glycosylation in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Downregulation of 15-hydroxyprostaglandin dehydrogenase in hormone-resistant breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Plasma MMP1, MMP8 and MMP13 expression in breast cancer: protective role of MMP8 against lymph node metastasis

01.05.2008 | Poster presentation | Sonderheft 2/2008

Association of MMP8 gene variation with breast cancer prognosis

01.05.2008 | Poster presentation | Sonderheft 2/2008

CD44 signalling increases cathepsin K and MT1MMP expression to potentiate breast cancer cell invasion through collagen I

01.05.2008 | Poster presentation | Sonderheft 2/2008

Overexpression of CD44 in acquired tamoxifen-resistant breast cancer cells augments their migratory response to heregulin beta 1

01.05.2008 | Poster presentation | Sonderheft 2/2008

Role of CLEVER-1 in breast cancer metastasis

01.05.2008 | Poster presentation | Sonderheft 2/2008

Characterization of a cytoskeletal signaling pathway underpinning CD44-initiated, integrin-mediated adhesion of breast cancer cells to bone marrow endothelium

01.05.2008 | Poster presentation | Sonderheft 2/2008

Identification of genes involved in the formation of lymph node metastasis from human tumour xenograft models of breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Matrix metalloproteinase-8 is a regulator of the clinical aggressiveness of mammary tumours

01.05.2008 | Poster presentation | Sonderheft 2/2008

Actions of IGF-I are differentially regulated by fatty acids in normal and breast cancer epithelial cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

Insulin-like growth factor binding protein 3 modulates epidermal growth factor (EGF)-induced growth of breast epithelial cells by altering EGF receptor internalization

01.05.2008 | Poster presentation | Sonderheft 2/2008

Anti-oestrogen therapy switches off tumour suppressors and proapoptotic genes in breast cancer and reveals a new therapeutic opportunity

01.05.2008 | Poster presentation | Sonderheft 2/2008

Zinc transporter HKE4 as a new target in antihormone resistance of breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Stromal fibroblasts with nuclear β-catenin are present within breast tumours and increase proliferation and invasion of epithelial breast cancer cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

Proapoptotic protein Bid is regulated by phosphorylation during anoikis and the cell cycle

01.05.2008 | Poster presentation | Sonderheft 2/2008

Breast cancer and environmental risk factors: an appraisal of the scientific evidence

01.05.2008 | Poster presentation | Sonderheft 2/2008

Assessment of angiogenesis in the hyperplasia preinvasive, invasive breast carcinoma sequence

01.05.2008 | Poster presentation | Sonderheft 2/2008

Altered myoepithelial cell expression and function in cancer-containing breasts

01.05.2008 | Poster presentation | Sonderheft 2/2008

Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk

01.05.2008 | Poster presentation | Sonderheft 2/2008

From association to cause: fine mapping of the TNRC9gene region, a novel susceptibility locus identified in the first genome-wide association study for breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Cytochrome P450 modulates the therapeutic actions of tamoxifen, as evidenced in novel breast cancer models

01.05.2008 | Poster presentation | Sonderheft 2/2008

Multicentre study of CASP8 polymorphisms in breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Abnormal expression of p53 isoforms can be associated with poor survival in primary breast tumours

01.05.2008 | Poster presentation | Sonderheft 2/2008

The effect of intermittent versus chronic energy restriction on breast cancer risk biomarkers in premenopausal women: a randomised pilot trial

01.05.2008 | Poster presentation | Sonderheft 2/2008

Living with genetic risk of breast cancer: what have we learned?

01.05.2008 | Poster presentation | Sonderheft 2/2008

Urinary and serum biomarkers of phytoestrogen exposure are not associated with breast cancer risk in the European Prospective into Cancer Norfolk study

01.05.2008 | Poster presentation | Sonderheft 2/2008

Adherence to hormone therapy in a chemoprevention randomised trial

01.05.2008 | Poster presentation | Sonderheft 2/2008

Health inequalities in breast cancer screening

01.05.2008 | Poster presentation | Sonderheft 2/2008

MCPH1, a potential predictor for response to cancer chemotherapy

01.05.2008 | Poster presentation | Sonderheft 2/2008

Quantitative proteomics reveals proteins associated with radiotherapy resistance in breast cancer cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

Identification of proteins associated with radiotherapy resistance in breast cancer cells: a combined proteomic and microarray screening approach

01.05.2008 | Poster presentation | Sonderheft 2/2008

Proteomic screening of 725 antibodies simultaneously using antibody microarray technology to identify proteins associated with radiotherapy resistance in breast cancer cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

Development of anti-MUC1 DNA aptamers for the imaging and radiotherapy of breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Prognostic significance of steroid receptor co-regulators in breast cancer: co-repressor NCOR2/SMRT is an independent indicator of poor outcome

01.05.2008 | Poster presentation | Sonderheft 2/2008

High-throughput optical proteomics and breast cancer patient profiling: novel applications to individualise prognosis and treatment

01.05.2008 | Poster presentation | Sonderheft 2/2008

Expression analysis of novel biomarkers for breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Identification and role of migration stimulating factor isoforms in breast carcinomas

01.05.2008 | Poster presentation | Sonderheft 2/2008

Development of functional assays for BRCA1 missense mutations

01.05.2008 | Poster presentation | Sonderheft 2/2008

Chemotherapy-induced modulation of [18F]Fluoro-2-deoxy-D-glucose incorporation at the tumour cell level

01.05.2008 | Poster presentation | Sonderheft 2/2008

Identification and definition of novel clinical phenotypes of breast cancer through consensus derived from automated clustering methods

01.05.2008 | Poster presentation | Sonderheft 2/2008

Detection of gene amplification in matched tumour and plasma DNA from breast cancer patients by quantitative PCR

01.05.2008 | Poster presentation | Sonderheft 2/2008

Prospective Study of Outcome in Sporadic versus Hereditary Breast Cancer: pros and cons of running a cohort study

01.05.2008 | Poster presentation | Sonderheft 2/2008

Lymphovascular invasion in breast cancer: improved methods of detection and clinical significance

01.05.2008 | Poster presentation | Sonderheft 2/2008

TARGIT: an international trial of intraoperative versus external beam radiotherapy

01.05.2008 | Poster presentation | Sonderheft 2/2008

Cambridge Breast Intensity Modulated Radiotherapy Trial: dosimetry results for 1,139 patients

01.05.2008 | Poster presentation | Sonderheft 2/2008

Bevacizumab resistance in breast cancer: are neuropilins the key?

01.05.2008 | Poster presentation | Sonderheft 2/2008

Brk expression may affect the differentiation status of breast cancer cells

01.05.2008 | Poster presentation | Sonderheft 2/2008

C35 overexpression defines subsets of human breast cancer and its immunoreceptor tyrosine-based activation motif represents a novel treatment target

01.05.2008 | Poster presentation | Sonderheft 2/2008

Why do most c-erbB-2/HER-2-positive breast cancer patients fail to respond to Herceptin?

01.05.2008 | Poster presentation | Sonderheft 2/2008

Identification of components of the ubiquitin system as targets for therapeutic intervention

01.05.2008 | Poster presentation | Sonderheft 2/2008

Pretreatment of breast cancer cells with doxorubicin facilitates the subsequent uptake of zoledronic acid

01.05.2008 | Poster presentation | Sonderheft 2/2008

Mechanisms of apoptosis and cell-cycle arrest in subcutaneous breast tumours treated sequentially with doxorubicin followed by zoledronic acid

01.05.2008 | Poster presentation | Sonderheft 2/2008

An exploration of the management of menopausal symptoms for women with a diagnosis of breast cancer: lay and professional experiences and expectations

01.05.2008 | Poster presentation | Sonderheft 2/2008

Investigation of immunoregulatory mechanisms relating to poor surgical wound healing and breast cancer recurrence

01.05.2008 | Poster presentation | Sonderheft 2/2008

Discrepancies and challenge of ductal carcinoma in situfor health professionals

01.05.2008 | Poster presentation | Sonderheft 2/2008

Exploring the breast cancer experiences, needs and preferences of women aged 70 years and over: a study in progress

01.05.2008 | Poster presentation | Sonderheft 2/2008

Exploring the acceptability of, and preferences for, an ongoing support network for known BRCA1 and BRCA2 mutation carriers

01.05.2008 | Poster presentation | Sonderheft 2/2008

The QUEST study: a multicentre randomised trial to assess the impact of the type and timing of breast reconstruction on quality of life following mastectomy

01.05.2008 | Poster presentation | Sonderheft 2/2008

'The sooner the better' or 'too much too soon'? A pilot prospective longitudinal study to evaluate quality of life and body image following immediate latissimus dorsi breast reconstruction

01.05.2008 | Poster presentation | Sonderheft 2/2008

Diagnosed with breast cancer whilst on a family history screening programme: an exploratory qualitative study

01.05.2008 | Poster presentation | Sonderheft 2/2008

'More positive about mammography' – reactions of women to a false positive recall: a qualitative study of women at risk of familial breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study (PIMMS)

01.05.2008 | Poster presentation | Sonderheft 2/2008

Food choice and phytoestrogen consumption in women previously treated for postmenopausal breast cancer

01.05.2008 | Poster presentation | Sonderheft 2/2008

Homeopathy service in an NHS hospital breast cancer clinic: outcome study

01.05.2008 | Poster presentation | Sonderheft 2/2008

Primary ductal carcinoma in situmammosphere formation: importance of the epidermal growth factor and Notch receptor signalling pathways

01.05.2008 | Poster presentation | Sonderheft 2/2008

PARP-1 inhibitor monotherapy and combination therapy in a preclinical mouse model of Brca2 mutant breast cancer

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise